Variations on fetal heart rate variability by Shaw, CJ et al.
J Physiol 594.5 (2016) pp 1279–1280 1279
Th
e
Jo
u
rn
al
o
f
Ph
ys
io
lo
g
y
TRANSLAT IONAL PERSPECT IVES
Variations on fetal heart rate
variability
C. J. Shaw1,2, C. C. Lees2
and D. A. Giussani1
1Department of Physiology, Development
andNeuroscience,University of Cambridge,
Cambridge, UK
2Institute of Reproductive and
Developmental Biology, Imperial College
London, London, UK
Email: dag26@cam.ac.uk
Intrapartum electronic fetal monitoring
(EFM) is widely used throughout the
developed and developing world. This
practice is based on the understanding
that fetal heart rate (FHR) is sensitive to
hypoxia. During labour, the fetus may be
exposed to acute hypoxia during uterine
contractions or intrapartum insults,
and has well-established cardiovascular
compensatory defence mechanisms,
which ideally prevent hypoxic–ischaemic
encephalopathy by maintaining perfusion
pressure and substrate delivery to essential
organs (Giussani et al. 1993). Failure of
these compensatory mechanisms results
in a progressively worsening metabolic
acidosis. Development of severe acidaemia
(pH < 7.05) is a key turning point after
which fetuses are unable to maintain fetal
cardiovascular defence mechanisms and
cerebral perfusion, rendering them at risk
of asphyxial brain injury (Gunn & Bennet,
2009). Therefore, intrapartum EFM aims
to identify, via changes in FHR patterns,
fetuses unable to initiate or maintain such
compensatory adaptations in response
to hypoxia, which become acidotic, and
deliver them before they are at risk of
asphyxia, severe acidosis, cardiovascular
collapse, end organ damage or death.
Retrospective analysis of intrapartumEFM
records shows that reduced or absent FHR
variability with decelerations is the most
consistent predictor of newborn acidaemia
and poor outcome (Parer & Ikeda, 2007).
However, the fetal physiology underlying
these changes is far from clear, as are the
changes in FHR patterns and variability
preceding this critical end-stage. While
knowledge of both fetal physiology and the
control of heart rate variability in the adult
has advanced greatly in the last 50 years
since intrapartum EFM was introduced,
little of it has translated into uncontested
interpretation of FHR patterns. It is clear
that without understanding the physiology
underlying the control of FHR and its
variability in normal and complicated
pregnancy, we will not move forwards
from retrospective analysis to prospective
prediction of abnormalities in the control of
FHRandhow these canbedetected by intra-
partum EFM. Such a change in approach is
long overdue. A recent Cochrane review of
13 randomised controlled trials concluded
that intrapartum EFM has not reduced the
rates of fetal mortality or cerebral palsy
and it has increased the rates of obstetric
intervention in labour, caesarean section,
operative vaginal delivery and delivery of
non-acidotic babies (Alfirevic et al. 2013).
Invasive adjuncts to EFM monitoring, such
as fetal blood sampling, as well as fetal pulse
oximetry and fetal electrocardiography
(measured as the T/QRS ratio) have
all been applied with limited success in
reducing operative delivery and without
significant improvement in neonatal
outcome (East et al. 2014). Guidelines and
recommendations for the interpretation
of intrapartum EFM exist, such as the
rule-based category colour-coded FHR
management framework championed by
Parer & Ikeda (2007). Adoption of such
frameworks in a single centrewith dedicated
training reduced the number of babies
born severely acidotic without altering the
rates of operative or instrumental delivery
(Katsuragi et al. 2014). However, despite
a general move towards standardised
assessment and the training of clinicians
to interpret intrapartum EFM with
reference to such guidelines, there remains
a well-acknowledged poor reliability
of EFM assessment between clinicians
(Blackwell et al. 2011). The chronically
instrumented fetal sheep preparation in
late gestation, which is uncomplicated by
general or local anaesthesia and in which
studies follow full post-surgical recovery,
provides an incomparable window into
fetal physiology that is inaccessible in the
human fetus. Not only can we control the
exact nature of the fetal insult in terms
of magnitude, duration and frequency,
but the preparation permits detailed fetal
cardiovascular function analysis over
prolonged periods, which can be correlated
to fetal endocrine as well as blood gas,
metabolic and acid/base status. Using this
experimental model, previous studies have
shown that acute hypoxia activates both
arms of the autonomic nervous system
controlling FHR but in favour of vagal
dominance and that activation of the
sympathetic nervous system (SNS) is key
to providing rapid support to increase fetal
peripheral vascular resistance and maintain
blood pressure despite slowing of the fetal
heart rate (Giussani et al. 1993). Further,
advancing gestational age (Fletcher et al.
2006) and antenatal glucocorticoid therapy
(Jellyman et al. 2005) affect the magnitude
and pattern of the FHR response to hypoxia
and of the fetal endocrine and metabolic
compensation, all of which contribute to
alterations in FHR variability. Surprisingly,
despite their physiological and clinical
importance, how gestational age or fetal
glucocorticoid status affects FHR variability
and how the mechanisms mediating FHR
variability during acute hypoxia are altered
in the chronically hypoxic IUGR fetus with
or without antenatal glucocorticoid therapy
still remain to be elucidated.
Increasing the body of knowledge of
the physiology underlying the control
of FHR variability, an interesting study
using the chronically instrumented fetal
ovine preparation by Lear and colleagues
in this issue of The Journal of Physio-
logy challenges the long held assumption
that the sympathetic nervous system
(SNS) mediates FHR variability in labour.
This finding directly contradicts the long
held clinical interpretation that preserved
FHR variability implies adequate fetal
physiological compensation. In this study,
analysis of fetal sheep which had been
chemically sympathectomised showed that
FHR variability between episodes of brief
repeated asphyxia or elevation of the ST
segment during asphyxia was unaltered
relative to sham control fetal sheep. Rather,
the data imply that the predominant
mediator of increased FHR variability
between episodes of brief intermittent
asphyxia was increased parasympathetic
activity. Therefore, if the SNS does
not influence FHR variability between
simulated contractions, interpretation of
FHR variability is unlikely to help monitor
changes in SNS activity during labour, a
significant change from traditional clinical
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understanding. Perhaps it is time to
re-examine the maxim, now 30 years
old and the basis of many obstetric
guidelines, that the fetus with a normal FHR
variability is at a low risk of immediate
death or brain injury caused by asphyxia,
regardless of the presence of decelerations
or bradycardia. There is an urgent need to
design experiments to address the under-
lying physiology mediating alterations in
FHR variability in healthy and complicated
pregnancy at different stages of gestation,
with and without exposure to common
antenatal therapies, such as treatment with
steroids. There is also the possibility that
the fetal heart may show intrinsic variability
in its heart rate, independent of auto-
nomic innervation, which can be altered by
gestational age, medications or the quality
of the intrauterine environment. Once
obtained, this information shouldbe rapidly
translated into frameworks for intrapartum
EFM interpretation, either by clinicians or,
more reliably, by a computer algorithm.
Only then will basic and clinical science act
in tandem to begin to reliably identify the
fetus at risk of decompensating, rather than
the already decompensated fetus.
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